Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

Tuesday, May 07 2024
10:00 AM – 10:20 AM ET - Ballroom 3

CMC considerations for adeno-associated virus (AAV)-vector based gene therapies - a CBER perspective

Bo Liang
FDA CBER OTAT

© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.